Affinity Asset Advisors »

Equillium shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Equillium (EQ) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Equillium

Tip: Access up to 7 years of quarterly data

All positions including Equillium held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Equillium by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.5M 1.2M 2.00

More positions owned by Affinity Asset Advisors

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Insmed Com Par $.01 (INSM)
Roivant Sciences SHS (ROIV)
Spyre Therapeutics Com New (SYRE)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Praxis Precision Medicines I Com New (PRAX)
Anaptysbio Inc Common (ANAB)
Alkermes SHS (ALKS)
Cytokinetics Com New (CYTK)
Abivax Sa Sponsored Ads (ABVX)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Arcellx Common Stock (ACLX)

View all positions for Affinity Asset Advisors

Top funds holding Equillium

Henderson Group
Adage Capital Partners GP
Decheng Capital
ADAR1 Capital Management
Woodline Partners
Standard Life Aberdeen
RA Capital Management
Vanguard Group
Vanguard Capital Management
Balyasny Asset Management
Eversept Partners
Affinity Asset Advisors
Renaissance Technologies
Diadema Partners
Hudson Bay Capital Management

View all funds holding Equillium